Stocky turns companies like MEDIBANK PRIVATE LIMITED into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Hold. MDBPF blends modest growth (53/100 compounder score) with reasonable valuation discipline (74/100 value score), but leadership alignment at 62.5/100 and a middling vulnerability profile (50/100 — adequate financial buffer only) leave little margin for error. Fair multiple and stable fundamentals don't justify overweighting.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for MEDIBANK PRIVATE LIMITED:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 64/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates MEDIBANK PRIVATE LIMITED (MDBPF) at 64/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. MDBPF blends modest growth (53/100 compounder score) with reasonable valuation discipline (74/100 value score), but leadership alignment at 62.5/100 and a middling vulnerability profile (50/100 — adequate financial buffer only) leave
MDBPF's current Stocky Verdict is 64/100, placing it in the "Hold" band. This composite combines a 74/100 Compounder score, 63/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for MEDIBANK PRIVATE LIMITED yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
MEDIBANK PRIVATE LIMITED scores 63/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
MEDIBANK PRIVATE LIMITED's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to MEDIBANK PRIVATE LIMITED.
Sign up free and unlock the full analysis on MDBPF — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for MDBPF in the app.
